Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Dynavax Technologies Corp. shares valued at $43,127 were sold by CANO FRANCIS on May 31 ’24. At $11.93 per share, CANO FRANCIS sold 3,615 shares. The insider’s holdings dropped to 36,905 shares worth approximately $0.42 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Burgess Justin sold 20,526 shares, netting a total of over 262,322 in proceeds. Following the sale of shares at $12.78 each, the insider now holds 0 shares.
Before that, Janssen Robert had sold 1,500 shares from its account. In a trade valued at $22,500, the SVP and CMO traded Dynavax Technologies Corp. shares for $15.00 each. Upon closing the transaction, the insider’s holdings decreased to 1,500 shares, worth approximately $0.57 million.
As published in their initiating research note from Goldman on February 01, 2024, Dynavax Technologies Corp. [DVAX] has been a Neutral and the price target has been revised to $20. Analysts at JMP Securities started covering the stock with ‘”a Mkt outperform”‘ outlook in a report released in late September. Earlier on August 06, 2021, Goldman initiated its rating. Their recommendation was “a Buy” for DVAX stock.
Analyzing DVAX Stock Performance
During the last five days, there has been a surge of approximately 10.17%. Over the course of the year, Dynavax Technologies Corp. shares have dropped approximately -17.88%. Shares of the company reached a 52-week high of $15.01 on 01/04/24 and a 52-week low of $10.23 on 07/19/24. A 50-day SMA is recorded $11.35, while a 200-day SMA reached $12.64. Nevertheless, trading volume fell to 1.72 million shares from 1.48 million shares the previous day.
Support And Resistance Levels for Dynavax Technologies Corp. (DVAX)
According to the 24-hour chart, there is a support level at 11.22, which, if violated, would cause prices to drop to 10.97. In the upper region, resistance lies at 11.67. The next price resistance is at 11.86. RSI (Relative Strength Index) is 57.63 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.40, which suggests the price will decrease in the coming days. Percent R is at 8.76%, indicating bullish price movement. Stochastics%K at selling indicates that the stock is to be held.
Which companies own the most shares of Dynavax Technologies Corp. (DVAX)?
On August 07, 2020, H.C. Wainwright assigned a price target of “a Buy” to the stock and reiterated coverage with a $12.
